Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 20 of 6351
-
Broader shield: can a 20-Valent vaccine outsmart pneumonia in babies?
Vaccine Recruiting nowThe purpose of this study is to evaluate a study vaccine called 20-valent pneumococcal conjugate vaccine (20vPnC). The study will assess whether the study vaccine is safe to use in healthy infants. It will also evaluate if the study vaccine can help the body make antibodies (know…
Phase 3 • Sponsor: Pfizer • Aim: Vaccine
Last updated Aug 12, 2026 00:00 UTC
-
Scientists harness Patients' own immune cells to attack Treatment-Resistant melanoma
Disease control Not yet recruitingThe goal of this study is to determine the activity of Perkileucel, a tumour infiltrating lymphocyte (TIL) adoptive cell transfer therapy (ACT), in patients with unresectable stage III or metastatic melanoma who have progressed on previous treatment with immune checkpoint inhibit…
Phase 2 • Sponsor: East Metropolitan Health Service, Australia • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a strict diet put type 2 diabetes into remission?
Disease control Recruiting nowThe goal of this clinical trial is to determine whether a low-calorie diet combined with intensive lifestyle intervention using Integrated Personalized Diabetes Management (iPDM) is more effective than standard care in achieving diabetes remission in adults with overweight and ty…
Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Could a simple blood and stool test slash gastrointestinal cancer deaths?
Diagnosis Recruiting nowThis study is a multicenter, randomized controlled trial. The plan is to enroll eligible participants and randomly assign them to two groups: one group will undergo testing using a combined model of "multi-target blood methylation + fecal FIT + fecal calpetin"; those with positiv…
Sponsor: Xijing Hospital • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
Can a new drug combo outsmart resistant myeloma?
Disease control Recruiting nowThe aim of the study is to assess the efficacy and safety of the BCD-248 in combination with daratumumab versus the combination of daratumumab, pomalidomide, and dexamethasone in the treatment of relapsed or refractory multiple myeloma. The study will be conducted in a population…
Phase 3 • Sponsor: Biocad • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
Can a diabetes drug ease the strain of a failing single-ventricle heart?
Disease control Recruiting nowSome people are born with a birth defect where they only have one functioning ventricle (lower chamber) in their heart. This condition can be initially managed with a Fontan operation, but there is a risk of developing Fontan Circulatory Failure (FCF) later in life. FCF occurs wh…
Phase 3 • Sponsor: Subodh Verma • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a targeted electric pulse therapy extend life in hard-to-treat pancreatic cancer?
Disease control Recruiting nowThis is a prospective, randomized, controlled, exploratory Phase II clinical study. Approximately 60 eligible patients with locally advanced pancreatic cancer who have received three cycles of chemotherapy induction and have non-progressive disease will be enrolled. All patients …
Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a new combo wipe out hepatitis b for good?
Cure Not yet recruitingThis is a real-world, prospective, multicenter, non-randomized, controlled study. It aims to investigate the efficacy and safety of pegylated interferon α-2b (PEG IFN α-2b) monotherapy versus its combination with nucleos(t)ide analogs (NAs) regarding hepatitis B surface antigen (…
Sponsor: xieqing • Aim: Cure
Last updated Jun 27, 2026 12:09 UTC
-
Can a Custom-Made genetic drug slow ALS?
Disease control By invitation onlyThis research project entails delivery of a personalized antisense oligonucleotide (ASO) drug designed for participants with amyotrophic lateral sclerosis (ALS) due to a pathogenic variant in TARDBP.
Phase 1/2 • Sponsor: n-Lorem Foundation • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New RSV vaccine trial aims to shield seniors from deadly lung infections
Vaccine Recruiting nowThis study will evaluate the efficacy of the Recombinant RSV vaccine(CHO cell) vaccine in preventing lower respiratory tract diseases(LRTD) caused by RSV in adults≥ 60 years of following a single dose of the RSV vaccine(CHO cell) vaccine .This study will also assess if the vaccin…
Phase 3 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: Vaccine
Last updated Jun 27, 2026 08:03 UTC
-
Monthly HIV prevention pill could replace daily dose
Prevention Recruiting nowResearchers are looking for new medicines to prevent HIV-1 (Human Immunodeficiency Virus Type 1) infection. The goals of this study are to learn: * If taking MK-8527 once a month works to prevent HIV-1 infection as well as or better than a standard (usual) pre-exposure prophyla…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Aug 26, 2026 00:00 UTC
-
Engineered immune cells aim to tame lupus without daily pills
Disease control OngoingThe purpose of this study is to evaluate the efficacy, safety and drug levels of CC-97540 in participants with active systemic lupus erythematosus (SLE) including lupus nephritis with inadequate response to glucocorticoids and at least 2 immunosuppressants.
Phase 2 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
One shot, six protections: could a single vaccine replace multiple infant shots?
Vaccine OngoingThe purpose of this study is to evaluate immunogenicity, safety and lot-to-lot consistency of LBVD in comparison to co-administration of Pentavalent vaccine and Poliomyelitis Vaccine (Inactivated) in separate injections at four weeks after completion of three-dose primary series …
Phase 2/3 • Sponsor: LG Chem • Aim: Vaccine
Last updated Sep 05, 2026 00:00 UTC
-
Can an immunotherapy boost standard treatment for a Head-and-Neck cancer?
Disease control OngoingThe main questions it aims to answer are: 1. Does the combination of GP induction chemotherapy and toripalimab improve the 3-year progression-free survival (PFS) compared to GP induction chemotherapy with placebo? 2. What are the differences in CR after induction therapy, 3-year…
Phase 3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a Pre-Transplant drug keep leukemia from returning?
Disease control Recruiting nowThis is a prospective, multicenter, randomized controlled trial designed to evaluate whether short-term blinatumomab intensification before allogeneic hematopoietic stem cell transplantation (allo-HSCT) can improve survival outcomes in adults with high-risk BCR::ABL1-negative B-c…
Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a direct brain infusion slow sanfilippo syndrome?
Disease control OngoingThe purpose of this study is to evaluate the safety, tolerability, efficacy, pharmacokinetics and pharmacodynamics of recombinant human heparan N-sulfatase (rhHNS, GC1130A) administered via intracerebroventricular access device in patients with Sanfilippo Syndrome Type A (MPS III…
Phase 1 • Sponsor: GC Biopharma Corp • Aim: Disease control
Last updated Sep 09, 2026 15:00 UTC
-
New mRNA vaccine aims to stop the stomach flu
Vaccine OngoingThe primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1403, and to demonstrate the efficacy of mRNA-1403 to prevent protocol-defined moderate or severe norovirus acute gastroenteritis (AGE) associated with vaccine matched genotypes.
Phase 3 • Sponsor: ModernaTX, Inc. • Aim: Vaccine
Last updated Jun 27, 2026 12:33 UTC
-
Can injecting immune drugs directly into tumors revive response to checkpoint inhibitors in melanoma?
Disease control Recruiting nowThe trial aims to evaluate the efficacy of single agent L19IL2, single agent L19TNF, and combination L19IL2+L19TNF given concurrently with anti-PD1 therapy compared to historical control of anti-PD-1 re-challenge alone for anti-PD1 refractory unresectable stage III-IV melanoma.
Phase 2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Mass antibiotic dosing could save thousands of children in niger
Disease control Recruiting nowSeveral randomized controlled trials have demonstrated that azithromycin mass drug administration (MDA) reduces child mortality, but increases antimicrobial resistance (AMR). The World Health Organization (WHO) guidelines for this intervention specify that implementation must be …
Phase 4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can new drug cocktails beat back Hard-to-Treat leukemia?
Disease control Recruiting nowTo study the optimal therapeutic strategies for salvage treatment of refractory/relapsed AML, and to clarify the effectiveness and safety of various salvage treatment options. A prospective, multicenter, platform-type study was conducted to explore the overall response rate, tole…
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC